GlassScriptPhysician profile
James T Bohmer
NPI 1184686008
$8,840.32
in general payments reported to CMS, 2019-2025
13 companies · $5,779 in 2025
The $5,779 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.44 · 2022: $1,542 · 2023: $619 · 2024: $868 · 2025: $5,779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Food and Beverage: $1,837 · Gift: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Food and Beverage | $1,837.43 |
| Gift | $177.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $5,903.27 | 2022-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Intuitive Surgical, INC. | $1,414.50 | 2021-2025 | Da Vinci Surgical System |
| Channel Medsystems, INC. | $257.25 | 2024-2025 | |
| Minerva Surgical, INC | $252.27 | 2025 | |
| Sumitomo Pharma America, INC. | $236.44 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $187.08 | 2022 | |
| Becton, Dickinson and Company | $150.74 | 2023 | Bd Onclarity |
| Conmed Corporation | $119.81 | 2022 | |
| Abbvie INC. | $118.17 | 2022-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Pfizer INC. | $74.09 | 2021-2024 | |
| Davol INC. | $60.15 | 2024 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $45.04 | 2022-2024 | Acessa Provu System |
| Scynexis, INC. | $21.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bohmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.